Read + Share
Douglas RS, Kahaly GJ, Ugradar S, Elflein H, et al. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye
Disease and Re-treatment: OPTIC-X Study. Ophthalmology 2022;129:438-449.
PMID: 34688699
|
 |
|
Douglas RS, Kahaly GJ, Ugradar S, Elflein H, et al. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye
Disease and Re-treatment: OPTIC-X Study. Ophthalmology 2022;129:438-449.
PMID: 34688699
|
|
|
|